15.11.2022 - PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and .
PAVmed (NASDAQ:PAVM – Get Rating) and LENSAR (NASDAQ:LNSR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends. Analyst Ratings This is a summary of current ratings for PAVmed […]
Zacks Investment Research upgraded shares of PAVmed (NASDAQ:PAVM – Get Rating) from a sell rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, “PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat […]
PAVmed Inc. (NASDAQ:PAVM – Get Rating) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 5,490,000 shares, a growth of 37.3% from the February 13th total of 4,000,000 shares. Based on an average daily trading volume, of 1,650,000 shares, the days-to-cover ratio is […]